A1 Refereed original research article in a scientific journal

Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease




AuthorsMurtomäki Kirsi, Joutsa Juho, Mertsalmi Tuomas, Jaakkola Elina, Mäkinen Elina, Levo Reeta, Eklund Mikael, Nuuttila Simo, Pekkonen Eero, Noponen Tommi, Ihalainen Toni, Kaasinen Valtteri, Scheperjans Filip

PublisherWILEY

Publication year2023

JournalBrain and Behavior

Journal name in sourceBRAIN AND BEHAVIOR

Journal acronymBRAIN BEHAV

Article numbere3097

Volume13

Issue7

Number of pages10

ISSN2162-3279

DOIhttps://doi.org/10.1002/brb3.3097

Web address https://onlinelibrary.wiley.com/doi/10.1002/brb3.3097

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/180000667


Abstract

Background: Gastrointestinal symptoms are common in Parkinson's disease (PD), but their neurophysiological correlates are not well understood. We recently reported that functional gastrointestinal symptoms were not associated with asymmetry per se but might be associated with lower left striatal dopamine transporter (DAT) binding. The purpose of this study was to further investigate if specific gastrointestinal symptoms associate with monoamine transporter changes in specific striatal or extrastriatal areas.

Methods: Ninety PD patients, who underwent DAT ¹2 3 I-FP-CIT SPECT imaging, were assessed using the MDS-Unified Parkinson's Disease Rating Scale part III, Rome III, and Wexner constipation score. DAT binding was calculated from striatal subregions using region-to-occipital cortex ratio. Voxel-wise analysis was used to assess the relationship between gastrointestinal symptoms and striatal DAT and extrastriatal serotonin transporter (SERT) binding.

Results: Irritable bowel syndrome (IBS) criteria were fulfilled in 17 patients and were linked to higher ¹2 3 I-FP-CIT binding in the right posterior putamen and adjacent areas as compared to patients without IBS. No other significant associations between gastrointestinal symptoms and DAT or SERT binding were found.

Conclusions: These findings suggest that PD patients with IBS may have higher DAT binding in the right hemisphere. This finding implicates alterations of brain neurotransmitter physiology in the gastrointestinal symptoms of PD patients.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 20:51